Preliminary criteria for the classification of systemic sclerosis (scleroderma)
about
Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosisStem cell transplantation for systemic sclerosisA nuclear target for interleukin-1alpha: interaction with the growth suppressor necdin modulates proliferation and collagen expressionHistometric data obtained by in vivo confocal laser scanning microscopy in patients with systemic sclerosisFunctional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosisClinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adultsTrends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studiesCancer incidence in systemic sclerosis: meta-analysis of population-based cohort studiesPrevalence of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French cohort and a systematic review and meta-analysisFactors associated with development of gastrointestinal problems in patients with scleroderma: a systematic reviewGastro-intestinal permeability is increased in patients with limited systemic sclerosisIdentification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assaySilicone breast implantation-induced scleroderma: description of four patients and a critical review of the literatureAssociation between the HLA-DRB1 gene and clinical features of systemic sclerosis in KoreaIdentification of Rare Variants in ATP8B4 as a Risk Factor for Systemic Sclerosis by Whole-Exome Sequencing.Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren's Syndrome and Systemic SclerosisIdentification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategyImmunogenicity and safety of two doses of a non-adjuvanted influenza A H1N1/2009 vaccine in young autoimmune rheumatic diseases patients.A preliminary study of skin ultrasound in diffuse cutaneous systemic sclerosis: Does skin echogenicity matter?Left atrial dysfunction detected by speckle tracking in patients with systemic sclerosis.Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive testsRole of 2D strain in the early identification of left ventricular dysfunction and in the risk stratification of systemic sclerosis patients.N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control studyB-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skinRecommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertensionText data extraction for a prospective, research-focused data mart: implementation and validation.Prevalence and incidence of systemic sclerosis in southern Sweden: population-based data with case ascertainment using the 1980 ARA criteria and the proposed ACR-EULAR classification criteria.Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial.Increased urinary F2-isoprostanes in systemic sclerosis, but not in primary Raynaud's phenomenon: effect of cold exposure.2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group.Application of the DETECT algorithm for detection of risk of pulmonary arterial hypertension in systemic sclerosis: data from a Czech tertiary centre.The 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis Could Classify Systemic Sclerosis Patients at Earlier Stage: Data from a Chinese EUSTAR CenterAssessment of abnormal blood flow and efficacy of treatment in patients with systemic sclerosis using a newly developed microwireless laser Doppler flowmeter and arm-raising test.Simple counting of nailfold capillary density in suspected systemic sclerosis - 9 years' experience.Differential dynamic properties of scleroderma fibroblasts in response to perturbation of environmental stimuliThrombotic thrombocytopenic purpura in a case of scleroderma renal crisis treated with twice-daily therapeutic plasma exchange.Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.Comparison of thermal infrared and laser doppler imaging in the assessment of cutaneous tissue perfusion in scleroderma patients and healthy controls.Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients.Systemic sclerosis with thrombotic thrombocytopenia purpura and malignant hypertension.
P2860
Q21144954-012D45B9-5DE0-4A47-A1D2-56D2FEF941A9Q24187598-EC78B9A6-7215-4940-ABAB-88264D73CF67Q24681313-817376F1-64ED-4790-95E3-B74BCF8BD201Q24799741-74E47066-9153-4802-A553-B151188B4BFFQ24814170-35100F8F-5A06-4A59-ABC4-FC74047909ABQ26852503-41533968-4B1A-4FB9-9378-0A1456348445Q26864958-B83B5E0E-C186-47C8-97A7-D705779876ACQ26998770-6AA317C3-6E20-4A0B-8EBE-85BDC48849DBQ27000819-98B2E767-EC6E-45BE-A9EF-361901F15F8FQ28077405-8BB99D6C-3EF3-4D85-9668-B704F3675607Q28182558-A2C54FC8-DCE0-4127-BEB2-69DCB2919692Q28208168-9481B821-CDEC-41F7-8CE0-EB46AE7280EAQ28263269-8EB92BB8-C8FF-41B8-A04C-BD0370825BCFQ28296258-D1408A55-B39C-4FB2-91B2-EB52B8734E5DQ28397539-309EA9AC-8976-497B-AB0D-19A2EA76D125Q28552792-F89B9B98-0645-47CE-9CEB-178E596A6E98Q29417020-58CF80D4-6502-41EB-925A-4DDEFAFF1657Q30354003-B497618B-F278-4240-AC0E-4F193304FACCQ30359351-9834FBE8-6A5F-499F-B26E-8E112E217AB1Q30432895-A7CF5186-BB09-42BF-BE87-EB2753E89C2AQ30453741-F2186D23-D7D2-419A-940A-E631EBC24624Q30458135-E014C4EC-9920-4B1C-A2DE-A89FE5F2AD5EQ30463476-AC6CD053-6772-49B7-81A1-FC0F327C9981Q30525106-A191DC1C-17E2-4C51-9C78-3DBA3AB13502Q30562538-0A8DF45A-214B-45B5-91AC-DE6FBB43D36DQ30564455-F7AB21CB-9593-4961-8745-F4E3F950C360Q30658087-52E15FA9-2D79-4D3E-8C3D-24DE33339E25Q30829854-1C5B5CE9-C7EA-4BCA-A69A-A0B0F03DB353Q30836387-BFCC619A-39AC-43A3-B64A-01A8BAFDCC65Q30853599-B2C2A190-4292-4CB1-85F8-ED4154C7FE65Q30990678-22FE749C-6876-4513-B6DD-5DED921395A9Q31142593-1380AB2F-2917-489C-923C-324B03A0366FQ33291222-7A02A4C3-BAF1-4CF1-8070-349BC84DC53EQ33311303-88880AD5-8E7C-42BD-95F6-3BC56401C69EQ33321260-8AF1CD54-E570-4766-942C-C4CDF585B6E6Q33339986-C84C5FE8-9450-4A69-874D-D2F88468D4ACQ33341941-65432139-6BA3-421A-90C6-AD4C6181FB67Q33373590-20854B89-F46B-4612-B1B3-131438F19A3BQ33375598-2BA541D8-351A-4E00-9B97-387DCC21D3E4Q33402720-18E4115C-669F-4DC9-AB0D-A76CA5981727
P2860
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 1980
@uk
name
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
@en
Preliminary criteria for the classification of systemic sclerosis
@nl
type
label
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
@en
Preliminary criteria for the classification of systemic sclerosis
@nl
prefLabel
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
@en
Preliminary criteria for the classification of systemic sclerosis
@nl
P356
P1476
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
@en
P2093
Alfonse T. Masi
P304
P356
10.1002/ART.1780230510
P577
1980-05-01T00:00:00Z